All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Current approaches to combination therapy for essential hypertension: the rationale for combined calcium, channel blockade and beta-blockade

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F13%3A00057977" target="_blank" >RIV/00023001:_____/13:00057977 - isvavai.cz</a>

  • Result on the web

    <a href="http://www.pccj.eu/images/stories/Supplements/PCCJ_Concor_AM_Position_Paper_WEB.pdf" target="_blank" >http://www.pccj.eu/images/stories/Supplements/PCCJ_Concor_AM_Position_Paper_WEB.pdf</a>

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Current approaches to combination therapy for essential hypertension: the rationale for combined calcium, channel blockade and beta-blockade

  • Original language description

    Despite the availability of effective therapies, there remains poor awareness, diagnosis and management of hypertension across the globe. Effective treatment requires an understanding of the underlying disease processes involved in hypertension which includes chronic increased sympathetic activity and peripheral resistance rather than focusing simply on blood pressure reduction. The differing pathophysiological response patterns of younger and older hypertensive patients require different treatment pathways and combination antihypertensive therapy is increasingly being used to tackle this heterogeneous condition and to meet international targets for blood pressure reduction. The combination of beta-blockers and calcium channel blockers is recommended in international guidelines for the effective management of hypertension. Combination of these two complementary drug classes targets both heart rate and high sympathetic activity, and abnormal peripheral vascular resistance and arterial s

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FA - Cardiovascular diseases including cardio-surgery

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2013

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Primary care cardiovascular Journal

  • ISSN

    1756-5138

  • e-ISSN

  • Volume of the periodical

    6

  • Issue of the periodical within the volume

    suppl. 2

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    9

  • Pages from-to

    "S1"-"S9"

  • UT code for WoS article

  • EID of the result in the Scopus database